Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on October 28, 2026

Oct. 28, 2026

UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer

Indeterminate GlobeNewswire

Oct. 28, 2026

ORYZON to participate in upcoming events in November

Indeterminate GlobeNewswire

Oct. 28, 2026

One Stop Systems Reports Q3 2026 Results

Indeterminate GlobeNewswire

Oct. 28, 2026

Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells

Indeterminate GlobeNewswire

Oct. 28, 2026

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 

Indeterminate GlobeNewswire

Oct. 28, 2026

Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

Oct. 28, 2026

Immutep Receives A$2.16 million French R&D Tax Incentive

Indeterminate GlobeNewswire

Oct. 28, 2026

Blue Lake Biotechnology Secures $5 Million Grant to Support Ongoing Pediatric Phase 1/2a Clinical Trial of Intranasal RSV Vaccine Candidate

Indeterminate GlobeNewswire

Oct. 28, 2026

PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections

Indeterminate GlobeNewswire

Oct. 28, 2026

Bilibili Inc. Announces Results of Extraordinary General Meeting

Indeterminate GlobeNewswire

Oct. 28, 2026

ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026

Indeterminate GlobeNewswire

Oct. 28, 2026

RedCloud Announces Issuance of Shares to Insiders in Private Placement at Price per Share of $0.25 for Aggregate Subscription Price of $7.9 million

Indeterminate GlobeNewswire

Oct. 28, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

Aventis Energy Enters into Option Agreement to Acquire the Past-Producing Seneca VMS Project in Southwestern British Columbia

Indeterminate GlobeNewswire

Oct. 28, 2026

OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET

Indeterminate GlobeNewswire

Oct. 28, 2026

SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®

Indeterminate GlobeNewswire

Oct. 28, 2026

Palvella Announces FDA Acceptance and Priority Review of QTORIN™ Rapamycin NDA; February 28, 2027 PDUFA Target Action Date Set

Indeterminate GlobeNewswire

Oct. 28, 2026

Enovix Declares New Warrant Dividend

Indeterminate GlobeNewswire

Oct. 28, 2026

Atico Continues to Extend the Ore Body at El Roble Mine in Colombia and Reports Multiple Higher-Grade Intercepts up to 18.6m of 7.65% Cu, 2.22 g/t Au, 9.0m of 8.44% Cu, 3.58 g/t Au and 5.7m of 8.48% Cu, 7.41 g/t Au

Indeterminate GlobeNewswire

Oct. 28, 2026

Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization

Indeterminate GlobeNewswire